🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amanda Rosewell Shaw

Houston Methodist

ORCID: 0000-0002-9642-3926

Also affiliated with University of South Carolina, Baylor College of Medicine, Benedict College, Methodist Hospital, Texas Children's Hospital

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors”.

Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors

Molecular Therapy(2020)10.1016/j.ymthe.2020.02.016
N/A
0DataRank · unranked
144 citations

Amanda Rosewell Shaw, Youngrock Jung, Tiffany Yip, Patricia Castro, Vlad C. Sandulache +6 more

Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment

Molecular Therapy(2020)10.1016/j.ymthe.2020.10.023
N/A
0DataRank · unranked
85 citations

Mary K. McKenna, Amanda Rosewell Shaw, Masataka Suzuki, Norihiro Watanabe

Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives

Cancers(2020)10.3390/cancers12030619
N/A
0DataRank · unranked
21 citations

Amanda Rosewell Shaw, Masataka Suzuki, Mary K. McKenna

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

Communications Biology(2021)10.1038/s42003-021-01914-8
N/A
0DataRank · unranked
43 citations

Caroline E. Porter, Tiffany Yip, Way-Champ Mah, Mary K. McKenna, Matthew Dysthe +5 more

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies

Science Advances(2023)10.1126/sciadv.ade6790
N/A
0DataRank · unranked
28 citations

Caroline E. Porter, Bora Lim, Amanda Rosewell Shaw, Catherine Robertson, Mae Woods +9 more

Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009741
N/A
0DataRank · unranked
7 citations

Amanda Rosewell Shaw, Greyson Biegert, Caroline E. Porter, Mae Woods, Spyridoula Vasileiou +3 more

Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity

Molecular Therapy — Methods & Clinical Development(2024)10.1016/j.omtm.2024.101279
N/A
0DataRank · unranked
3 citations

Arianexys Aquino Lόpez, A Wolff, Audrey Ma, Amanda Rosewell Shaw, Masataka Suzuki +3 more

IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200899
N/A
0DataRank · unranked
3 citations

Daisuke Morita, Caroline E. Porter, Eric Tu, Greyson Biegert, Sonia Agrawal +4 more

Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201006
N/A
0DataRank · unranked
5 citations

Amanda Rosewell Shaw, Daisuke Morita, Caroline B. M. Porter, Ryu Matsumoto, Lisa Jatta +6 more

Alternative splicing of KLF4 in myeloid cells: implications for cellular plasticity and trained immunity in cancer and inflammatory disease

Frontiers in Immunology(2025)10.3389/fimmu.2025.1585528
N/A
0DataRank · unranked
3 citations

Attoria Bennett, Daping Fan, Walden Ai, Amanda Rosewell Shaw